참고문헌
- Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics. Pediatrics 2000;105:1158-1170. https://doi.org/10.1542/peds.105.5.1158
- Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 1998;279:1100-1107. https://doi.org/10.1001/jama.279.14.1100
- Cho SC. Concept and biological study of attention deficit hyperactivity disorder. J Korean Acad Child Adolesc Psychiatry 1990;1:5-26.
- Ahn DH, Hong KE. Management of the child with attention - deficit hyperactivity disorders (ADHD). J Korean Acad Child Adolesc Psychiatry 1990;1:77-88.
- Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996;35:409-432. https://doi.org/10.1097/00004583-199604000-00008
- Yang YH, Yoo HJ. Stimulants medication of attention-deficit hyperactivity disorder. J Korean Acad Child Adolesc Psychiatry 2008;19:61-71.
- Lewis M. Child and adolescent psychiatry: a comprehensive textbook. Philadelphia, PA: Lippincott Williams & Wilkins;2002.
- Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1999;38:1551-1559. https://doi.org/10.1097/00004583-199912000-00017
- Cheng JY, Chen RY, Ko JS, Ng EM. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis. Psychopharmacology (Berl) 2007;194:197-209. https://doi.org/10.1007/s00213-007-0840-x
- Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A metaanalysis. CMAJ 2001;165:1475-1488.
- Barkley RA, McMurray MB, Edelbrock CS, Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 1990;86:184-192.
- Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 2001;40:168-179. https://doi.org/10.1097/00004583-200102000-00011
- Yoo HJ, Yang SJ, Shin D, Kang H, Kim BN, Kim JH, et al. The Korean practice parameter for the treatment of attention-deficit hyperactivity disorder(III): pharmacologic treatment. J Korean Acad Child Adolesc Psychiatry 2007;18:16-25.
- Conners CK, Epstein JN, March JS, Angold A, Wells KC, Klaric J, et al. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry 2001;40:159-167. https://doi.org/10.1097/00004583-200102000-00010
- Berger I, Dor T, Nevo Y, Goldzweig G. Attitudes toward attentiondeficit hyperactivity disorder (ADHD) treatment: parents' and children's perspectives. J Child Neurol 2008;23:1036-1042. https://doi.org/10.1177/0883073808317726
- Dunnick JK, Hailey JR. Experimental studies on the long-term effects of methylphenidate hydrochloride. Toxicology 1995;103:77-84. https://doi.org/10.1016/0300-483X(95)03109-S
- Pelham WE Jr, Waschbusch DA. Behavioral intervention in attention- deficit/hyperacivity disorder. In: Quay HC, Hogan AE, editors. Handbook of disruptive behavior disorders. New York: Springer; 1999. p.255-278.
- Kim BN, Yoo HK, Kang H, Kim JH, Shin D, Ahn D, et al. The Korean practice parameter for the treatment of attention-deficit hyperactivity disorder (IV): non-pharmacologic treatment. J Korean Acad Child Adolesc Psychiatry 2007;18:26-30.
- Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA 2010;304:875-880. https://doi.org/10.1001/jama.2010.1192
- Pelham WE Jr, Wheeler T, Chronis A. Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol 1998;27:190-205. https://doi.org/10.1207/s15374424jccp2702_6
- Barkley RA, DuPaul GJ, McMurray MB. Comprehensive evaluation of attention deficit disorder with and without hyperactivity as defined by research criteria. J Consult Clin Psychol 1990;58:775-789. https://doi.org/10.1037/0022-006X.58.6.775
- Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging 2006;10:377-385.
- Fernstrom JD. Can nutrient supplements modify brain f unction? Am J Clin Nutr 2000;71(6 Suppl):1669S-1675S. https://doi.org/10.1093/ajcn/71.6.1669S
- Sarris J, Kean J, Schweitzer I, Lake J. Complementary medicines (herbal and nutritional products) in the treatment of attention deficit hyperactivity disorder (ADHD): a systematic review of the evidence. Complement Ther Med 2011;19:216-227. https://doi.org/10.1016/j.ctim.2011.06.007
- Arnold LE, Hurt E, Lofthouse N. Attention-deficit/hyperactivity disorder: dietary and nutritional treatments. Child Adolesc Psychiatr Clin N Am 2013;22:381-402, v. https://doi.org/10.1016/j.chc.2013.03.001
- Rucklidge JJ, Johnstone J, Kaplan BJ. Nutrient supplementation approaches in the treatment of ADHD. Expert Rev Neurother 2009;9:461-476. https://doi.org/10.1586/ern.09.7
- Sinn N, Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. J Dev Behav Pediatr 2007;28:82-91. https://doi.org/10.1097/01.DBP.0000267558.88457.a5
- Gustafsson PA, Birberg-Thornberg U, Duchén K, Landgren M, Malmberg K, Pelling H, et al. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. Acta Paediatr 2010;99:1540-1549. https://doi.org/10.1111/j.1651-2227.2010.01871.x
-
Perera H, Jeewandara KC, Seneviratne S, Guruge C. Combined
${\omega}3$ and${\omega}6$ supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double- blind, placebo-controlled study. J Child Neurol 2012;27:747-753. https://doi.org/10.1177/0883073811435243 - Yehuda S, Rabinovitz-Shenkar S, Carasso RL. Effects of essential fatty acids in iron deficient and sleep-disturbed attention deficit hyperactivity disorder (ADHD) children. Eur J Clin Nutr 2011;65:1167-1169. https://doi.org/10.1038/ejcn.2011.80
- Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:233-239. https://doi.org/10.1016/S0278-5846(01)00254-8
- Vaisman N, Kaysar N, Zaruk-Adasha Y, Pelled D, Brichon G, Zwingelstein G, et al. Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids. Am J Clin Nutr 2008;87:1170-1180. https://doi.org/10.1093/ajcn/87.5.1170
- Manor I, Magen A, Keidar D, Rosen S, Tasker H, Cohen T, et al. The effect of phosphatidylserine containing omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension. Eur Psychiatry 2012;27:335-342. https://doi.org/10.1016/j.eurpsy.2011.05.004
- Milte CM, Parletta N, Buckley JD, Coates AM, Young RM, Howe PR. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial. Nutrition 2012;28:670-677. https://doi.org/10.1016/j.nut.2011.12.009
- Stevens L, Zhang W, Peck L, Kuczek T, Grevstad N, Mahon A, et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids 2003;38:1007-1021. https://doi.org/10.1007/s11745-006-1155-0
- Raz R, Carasso RL, Yehuda S. The influence of short-chain essential fatty acids on children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol 2009;19:167-177. https://doi.org/10.1089/cap.2008.070
- Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr 2001;139:189-196. https://doi.org/10.1067/mpd.2001.116050
- Johnson M, Ostlund S, Fransson G, Kadesjö B, Gillberg C. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J Atten Disord 2009;12:394-401. https://doi.org/10.1177/1087054708316261
- Bélanger SA, Vanasse M, Spahis S, Sylvestre MP, Lippe S, L'heureux F, et al. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: a randomized, double-blind, placebo-controlled study. Paediatr Child Health 2009;14:89-98. https://doi.org/10.1093/pch/14.2.89
- Aman MG, Mitchell EA, Turbott SH. The effects of essential fatty acid supplementation by Efamol in hyperactive children. J Abnorm Child Psychol 1987;15:75-90. https://doi.org/10.1007/BF00916467
- Arnold LE, Kleykamp D, Votolato NA, Taylor WA, Kontras SB, Tobin K. Gamma-linolenic acid for attention-deficit hyperactivity disorder: placebo-controlled comparison to D-amphetamine. Biol Psychiatry 1989;25:222-228. https://doi.org/10.1016/0006-3223(89)90167-4
- Hirayama S, Hamazaki T, Terasawa K. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study. Eur J Clin Nutr 2004;58:467-473. https://doi.org/10.1038/sj.ejcn.1601830
- Raz R, Gabis L. Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Dev Med Child Neurol 2009; 51:580-592. https://doi.org/10.1111/j.1469-8749.2009.03351.x
- Hawkey E, Nigg JT. Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. Clin Psychol Rev 2014;34:496-505. https://doi.org/10.1016/j.cpr.2014.05.005
- Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991;54:438-463. https://doi.org/10.1093/ajcn/54.3.438
- Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002;21:495-505. https://doi.org/10.1080/07315724.2002.10719248
- Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995;62:761-768. https://doi.org/10.1093/ajcn/62.4.761
- Antalis CJ, Stevens LJ, Campbell M, Pazdro R, Ericson K, Burgess JR. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2006;75:299-308. https://doi.org/10.1016/j.plefa.2006.07.004
- Joshi K, Lad S, Kale M, Patwardhan B, Mahadik SP, Patni B, et al. Supplementation with flax oil and vitamin C improves the outcome of attention deficit hyperactivity disorder (ADHD). Prostaglandins Leukot Essent Fatty Acids 2006;74:17-21. https://doi.org/10.1016/j.plefa.2005.10.001
- Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 2006;75:259-269. https://doi.org/10.1016/j.plefa.2006.07.005
- Drane DL, Logemann JA. A critical evaluation of the evidence on the association between type of infant feeding and cognitive development. Paediatr Perinat Epidemiol 2000;14:349-356. https://doi.org/10.1046/j.1365-3016.2000.00301.x
- Belfort MB, Rifas-Shiman SL, Kleinman KP, Guthrie LB, Bellinger DC, Taveras EM, et al. Infant feeding and childhood cognition at ages 3 and 7 years: effects of breastfeeding duration and exclusivity. JAMA Pediatr 2013;167:836-844. https://doi.org/10.1001/jamapediatrics.2013.455
- Arnold LE, Kleykamp D, Votolato N, Gibson RA, Horrocks L. Potential link between dietary intake of fatty acids and behavior: pilot exploration of serum lipids in attention-deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 1994;4:171-182. https://doi.org/10.1089/cap.1994.4.171
- Brue AW, Oakland TD, Evans RA. The use of a dietary supplement combination and an essential fatty acid as an alternative and complementary treatment for children with attention-deficit/hyperactivity disorder. Sci Rev Altern Med 2001;5:187-194.